Back pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age (between 18 and 80 years); orientation in time, space and person; presence of chronic pain in the vertebral column for three months or more, of any origin; self-report of pain intensity bigger or equal 4, and availability of time for submission to treatment sessions.
Exclusion criteria
Exclusion criteria: Infection, inflammation or injury in the ear; use of piercing (except normal earring); allergy to metal or micropore; decreased skin turgor, skin lesions or diseases in the dorsal region; treatments with anticoagulant; use of other energy therapies (massage, herbal medicine, reiki, floral therapy) up to three months prior to the study; physiotherapy treatment concomitant with the proposed interventions; continuous use of medication for pain relief; neurological, psychiatric or rheumatic disease; pregnancy; breastfeeding; and not respond to three attempts of contact made by the researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intensity of chronic pain, verified by means of the Brief Pain Inventory, from the observation of a variation of at least 2 points in the pre- and post-intervention measurements. The primary outcome will be assessed before starting treatment sessions and after each session, and seven, 15 days and 30 days after the end of the procedure. | — |
Secondary
| Measure | Time frame |
|---|---|
| Interference in daily activities, verified through the Brief Inventory of Pain, evaluated before starting the treatment sessions and after each session, and 7, 15 days and 30 days after the end of the procedure. An improvement in pain interference is expected in patients' daily activities. ;Physical disability, verified by Rolland Morris Disability Questionnaire for general pain, assessed prior to initiating treatment sessions and after each session, and seven, 15 days, and 30 days after the end of the procedure. An improvement in the patients' physical disability is expected. ;Quality of life, verified through the Medical Outcomes Study 36 - Item short-form health survey (SF-36), evaluated before starting the treatment sessions and after each session, and seven, 15 days and 30 days after the end of the procedure. The quality of life of patients is expected to improve.;Nociceptive threshold, verified by a digital algometer, evaluated before starting the treatment sessions and after each session, and seven, 15 days and 30 days after the end of the procedure. An increase in the nociceptive threshold of patients is expected. | — |
Countries
Brazil
Contacts
Universidade Federal de Minas Gerais